BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37855047)

  • 1. Overcoming barriers to lung cancer screening using a systemwide approach with additional focus on the non-screened.
    Gieske MR; Kerns J; Schmitt GM; Kloecker G; Budhani IA; Nolan J; Williams VA; Alkapalan D; Ferguson K; Yadav R; Calhoun RF
    J Med Screen; 2024 Jun; 31(2):99-106. PubMed ID: 37855047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
    Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
    JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to Lung Cancer Screening With Low-Dose Computed Tomography.
    Lei F; Lee E
    Oncol Nurs Forum; 2019 Mar; 46(2):E60-E71. PubMed ID: 30767965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
    Li J; Chung S; Wei EK; Luft HS
    BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
    Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
    JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation.
    Japuntich SJ; Krieger NH; Salvas AL; Carey MP
    J Natl Med Assoc; 2018 Oct; 110(5):424-427. PubMed ID: 30129479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, Race, and Income Are Associated With Lower Screening Rates at a Safety Net Hospital.
    Steiling K; Loui T; Asokan S; Nims S; Moreira P; Rebello A; Litle VR; Suzuki K
    Ann Thorac Surg; 2020 May; 109(5):1544-1550. PubMed ID: 31981498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study.
    Kanodra NM; Pope C; Halbert CH; Silvestri GA; Rice LJ; Tanner NT
    Ann Am Thorac Soc; 2016 Nov; 13(11):1977-1982. PubMed ID: 27676369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
    Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
    J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.
    Richards TB; Doria-Rose VP; Soman A; Klabunde CN; Caraballo RS; Gray SC; Houston KA; White MC
    Am J Prev Med; 2019 Jan; 56(1):66-73. PubMed ID: 30467092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trial.
    Gerber DE; Hamann HA; Santini NO; Abbara S; Chiu H; McGuire M; Quirk L; Zhu H; Lee SJC
    Contemp Clin Trials; 2017 Sep; 60():78-85. PubMed ID: 28689056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
    Hüsing A; Kaaks R
    Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of Chronic Smoking Behavior and Eligibility for Low-Dose Computed Tomography for Lung Cancer Screening Among Older Chinese Male Smokers.
    Li CC; Matthews AK; Dong X
    J Gerontol A Biol Sci Med Sci; 2017 Jul; 72(suppl_1):S22-S25. PubMed ID: 28575258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China.
    Guo LW; Chen Q; Shen YC; Meng QC; Zheng LY; Wu Y; Cao XQ; Xu HF; Liu SZ; Sun XB; Qiao YL; Zhang SK
    JAMA Netw Open; 2020 Nov; 3(11):e2019039. PubMed ID: 33141158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Results From the Implementation of a Lung Cancer Screening Program: The Beaumont Health System Experience.
    Lanni TB; Stevens C; Farah M; Boyer A; Davis J; Welsh R; Keena D; Akhtar A; Mezwa D
    Am J Clin Oncol; 2018 Mar; 41(3):218-222. PubMed ID: 26650780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
    Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
    Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus Groups and In-depth Interviews to Guide the Development of Lung Cancer Screening Informational Materials.
    Sharma A; O'Connor R; Celestino P; Killion S; Griswold-Krupski L; Bansal-Travers M
    J Cancer Educ; 2019 Aug; 34(4):712-718. PubMed ID: 29679265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
    Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
    J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.